PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions von Konecny, G E, Kristeleit, R S

Volltext

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes von VON MINCKWITZ, Gunter, UNTCH, Michael, JACKISCH, Christian, KAUFMANN, Manfred, KONECNY, Gottfried E, DENKERT, Carsten, NEKLJUDOVA, Valentina, MEHTA, Keyur, LOIBL, Sibylle, BLOHMER, Jens- Uwe, COSTA, Serban D, EIDTMANN, Holger, FASCHING, Peter A, GERBER, Bernd, EIERMANN, Wolfgang, HILFRICH, Jörn, HUOBER, Jens

Volltext

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer von KONECNY, Gottfried E, CHEN WANG, GOSTOUT, Bobbie, PODRATZ, Karl C, KEENEY, Gary, WANG, He-Jing, HARTMANN, Lynn C, SLAMON, Dennis J, GOODE, Ellen L, HAMIDI, Habib, WINTERHOFF, Boris, KALLI, Kimberly R, DERING, Judy, GINTHER, Charles, CHEN, Hsiao-Wang, DOWDY, Sean, CLIBY, William

Volltext

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma von Lin, Kevin K, Harrell, Maria I, Oza, Amit M, Oaknin, Ana, Ray-Coquard, Isabelle, Tinker, Anna V, Helman, Elena, Radke, Marc R, Say, Carmen, Vo, Lan-Thanh, Mann, Elaina, Isaacson, Jeffrey D, Maloney, Lara, O'Malley, David M, Chambers, Setsuko K, Kaufmann, Scott H, Scott, Clare L, Konecny, Gottfried E, Coleman, Robert L, Sun, James X, Giordano, Heidi, Brenton, James D, Harding, Thomas C, McNeish, Iain A, Swisher, Elizabeth M

Volltext

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: R... von UNTCH, Michael, FASCHING, Peter A, STICKELER, Elmar, HARBECK, Nadia, HÖSS, Cornelia, KAHLERT, Steffen, BECK, Thomas, FETT, Werner, MEHTA, Keyur M, VON MINCKWITZ, Gunter, LOIBL, Sibylle, KONECNY, Gottfried E, HASMÜLLER, Stephan, LEBEAU, Annette, KREIENBERG, Rolf, CAMARA, Oumar, MÜLLER, Volkmar, DU BOIS, Andreas, KÜHN, Thorsten

Volltext

Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells von KONECNY, Gottfried E, PEGRAM, Mark D, KEITH, Barry R, GILMER, Tona M, BERGER, Mark, PODRATZ, Karl C, SLAMON, Dennis J, VENKATESAN, Natarajan, FINN, Richard, GUORONG YANG, RAHMEH, Martina, UNTCH, Michael, RUSNAK, David W, SPEHAR, Glenn, MULLIN, Robert J

Volltext

Rational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast Cancer von Pegram, Mark D., Konecny, Gottfried E., O'Callaghan, Carminda, Beryt, Malgorzata, Pietras, Richard, Slamon, Dennis J.

Volltext

Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer von KONECNY, Gottfried E, WINTERHOFF, Boris, KALLI, Kimberly R, FINN, Richard S, GINTHER, Charles, JONES, Siân, VELCULESCU, Victor E, RIEHLE, Darren, CLIBY, William A, RANDOLPH, Sophia, KOEHLER, Maria, HARTMANN, Lynn C, KOLAROVA, Teodora, SLAMON, Dennis J, JINGWEI QI, MANIVONG, Kanthinh, DERING, Judy, GUORONG YANG, CHALUKYA, Meenal, WANG, He-Jing, ANDERSON, Lee

Volltext

Second-line dovitinib (TKI258) in patients with FGFR2 -mutated or FGFR2 -non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage,... von Konecny, Gottfried E, Dr, Finkler, Neil, Prof, Garcia, Agustin A, MD, Lorusso, Domenica, MD, Lee, Paula S, MD, Rocconi, Rodney P, MD, Fong, Peter C, MBBS, Squires, Matt, PhD, Mishra, Kaushal, PhD, Upalawanna, Allison, PharmD, Wang, Yongyu, MD, Kristeleit, Rebecca, MD

Volltext

Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer:... von MOEBUS, Volker, JACKISCH, Christian, HARBECK, Nadia, VON MINCKWITZ, Gunter, RUNNEBAUM, Ingo B, HINKE, Axel, KREIENBERG, Rolf, KONECNY, Gottfried E, UNTCH, Michael, LUECK, Hans-Joachim, DU BOIS, Andreas, THOMSSEN, Christoph, KURBACHER, Christian, KUHN, Walther, NITZ, Ulrike, SCHNEEWEISS, Andreas, HUOBER, Jens

Volltext

Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma von SANTISKULVONG, Chintda, KONECNY, Gottfried E, FEKETE, Mirela, CHEN, Kuang-Yui Michael, KARAM, Amer, MULHOLLAND, David, ENG, Carol, HONG WU, MIN SONG, DORIGO, Oliver

Volltext

Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2 and RAD51C Status von Cunningham, J. M., Cicek, M. S., Larson, N. B., Davila, J., Wang, C., Larson, M. C., Song, H., Dicks, E. M., Harrington, P., Wick, M., Winterhoff, B. J., Hamidi, H., Konecny, G. E., Chien, J., Bibikova, M., Fan, J.-B., Kalli, K. R., Lindor, N. M., Fridley, B. L., Pharoah, P. P. D., Goode, E. L.

Volltext

Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures von Winterhoff, Boris, Hamidi, Habib, Wang, Chen, Kalli, Kimberly R, Fridley, Brooke L, Dering, Judy, Chen, Hsiao-Wang, Cliby, William A, Wang, He-Jing, Dowdy, Sean, Gostout, Bobbie S, Keeney, Gary L, Goode, Ellen L, Konecny, Gottfried E

Volltext

Inhibition of PD-1 and VEGF in microsatellite-stable endometrial cancer von Konecny, Gottfried E

Volltext

Strategies for prevention and management of ocular events occurring with mirvetuximab soravtansine von Hendershot, Andrew, Slabaugh, Mark, Riaz, Kamran M., Moore, Kathleen N., O'Malley, David M., Matulonis, Ursula, Konecny, Gottfried E.

Volltext

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubici... von Untch, M., von Minckwitz, G., Konecny, G.E., Conrad, U., Fett, W., Kurzeder, C., Lück, H.-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Beckmann, M.W., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Nekljudova, V., Lebeau, A., Loibl, S., Fasching, P.A.

Volltext

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin... von Untch, M., Fasching, P.A., Konecny, G.E., von Koch, F., Conrad, U., Fett, W., Kurzeder, C., Lück, H.-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Schuster, T., Nekljudova, V., Lebeau, A., Loibl, S., von Minckwitz, G.

Volltext

Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mes... von Samiei, Alireza, Gjertson, David W, Memarzadeh, Sanaz, Konecny, Gottfried E, Moatamed, Neda A

Volltext

Activity of the multikinase inhibitor dasatinib against ovarian cancer cells von Konecny, G E, Glas, R, Dering, J, Manivong, K, Qi, J, Finn, R S, Yang, G R, Hong, K-L, Ginther, C, Winterhoff, B, Gao, G, Brugge, J, Slamon, D J

Volltext

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer von Fejzo, Marlena S, Anderson, Lee, von Euw, Erika M, Kalous, Ondrej, Avliyakulov, Nuraly K, Haykinson, Michael J, Konecny, Gottfried E, Finn, Richard S, Slamon, Dennis J

Volltext